Trial Profile
Effects of bronchodilatation with salmeterol on the autonomic nervous system
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Salmeterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; GSK
- 30 Nov 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 25 Apr 2012 New trial record